Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Prognostic Characterization of Advanced Mastocytosis Patients Treated with Midostaurin According to Diagnosis and Mutation-Adjusted Risk Score: A Nation-Wide Ceremast Study of 170 Patients

Mael Heiblig, Clement Gourguechon, Philippe Guilpain, Cristina Bulai Livideanu, Stéphane Barete, Julie Agopian, Fabienne Brenet, Patrice Dubreuil, Richard Lemal, Olivier Tournilhac, Louis Terriou, David Launay, Laurence Bouillet, Gandhi Laurent Damaj, Thomas Ballul, Céline Greco, Laura Polivka, Laurent Frenzel, Cecile Meni, Hassiba Bouktit, Caroline Gaudy-Marqueste, Marie Gousseff, Edwige Le Mouel, Antoine Neel, Dana Ranta, Roland Jaussaud, Thierry Jo Molina, Julie Bruneau, Ludovic Lhermitte, Marie Temple, Olivier Kosmider, Rose-Marie Javier, Fabien Pelletier, Florence Castelain, Frédérique Retornaz, Quentin Cabrera, Patricia Zunic, Marie-Pierre Gourin, Ewa Wierzbicka-Hainaut, Jean-Francois Viallard, Christian Lavigne, Cyrille Hoarau, Isabelle Durieu, Sophie Dimicoli-Salazar, Jose-Miguel Torregrosa-Diaz, Angele Soria, Michel Arock, Christine Bodemer, Olivier Lortholary, Olivier Hermine, Julien Rossignol

Blood (2023) 142 (Supplement 1): 1837.

https://doi.org/10.1182/blood-2023-185890

Published: 2023

Journal Articles

GlcNAc is a mast-cell chromatin-remodeling oncometabolite that promotes systemic mastocytosis aggressiveness

Julie Agopian, Quentin Da Costa, Quang Vo Nguyen, Giulia Scorrano, Paraskevi Kousteridou, Min Yuan, Rabie Chelbi, Armelle Goubard, Remy Castellano, Julien Maurizio, Cristina Teodosio, Paulo De Sepulveda, John M. Asara, Alberto Orfao, Olivier Hermine, Patrice Dubreuil, Fabienne Brenet

Blood (2021) 138 (17): 1590–1602.

https://doi.org/10.1182/blood.2020008948

Published: 2021

Includes: Supplemental data

Journal Articles

Megakaryocyte TGFβ1 partitions erythropoiesis into immature progenitor/stem cells and maturing precursors

Silvana Di Giandomenico, Pouneh Kermani, Nicole Mollé, Maria Mia Yabut, Ghaith Abu-Zeinah, Thomas Stephens, Nassima Messali, Ryan Schreiner, Fabienne Brenet, Shahin Rafii, Joseph M. Scandura

Blood (2020) 136 (9): 1044–1054.

https://doi.org/10.1182/blood.2019003276

Published: 2020

Includes: Supplemental data

Journal Articles

Megakaryocytic TGFβ1 Partitions Hematopoiesis into Amplifying Stem and Progenitor Cells and Maturing Effector Cells

Silvana Di Giandomenico, PhD, Pouneh Kermani, PhD, Nicole Molle, BS, Mia Yabut, BS, Fabienne Brenet, PhD, Shahin Rafii, MD, Joseph Scandura, MDPhD

Blood (2017) 130 (Supplement 1): 81.

https://doi.org/10.1182/blood.V130.Suppl_1.81.81

Published: 2017

Journal Articles

Controlling Hematopoietic Stem Cell Quiescence By Ablating the TGFβ-Responsive, Hematopoietic-Hpecific Enhancer of CDKN1C (p57)

Mia Yabut, BS, Fabienne Brenet, PhD, Nassima Messali, PhD, Nicole Molle, BS, Pouneh Kermani, PhD, Silvana Di Giandomenico, PhD, Matthew Brown, BS, Joseph Scandura, MDPhD

Blood (2017) 130 (Supplement 1): 2436.

https://doi.org/10.1182/blood.V130.Suppl_1.2436.2436

Published: 2017

Journal Articles

Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML

Joseph M. Scandura, Gail J. Roboz, Michelle Moh, Ewelina Morawa, Fabienne Brenet, J. Robi Bose, Luis Villegas, Usama S. Gergis, Sebastian A. Mayer, Cindy M. Ippoliti, Tania J. Curcio, Ellen K. Ritchie, Eric J. Feldman

Blood (2011) 118 (6): 1472–1480.

https://doi.org/10.1182/blood-2010-11-320093

Published: 2011

Includes: Supplemental data

Journal Articles

Genome-Wide Analysis of DNA Methylation Patterns Reveals Dynamic Epigenetic Regulation of the AML Genome After Decitabine Treatment.

Fabienne Brenet, Ph.D., Michelle Moh, MS, Patricia Funk, BS, Daoqui You, MS, Agnes J. Viale, Ph.D., Nicholas D. Socci, PhD, Joseph M. Scandura, MD, PhD

Blood (2009) 114 (22): 591.

https://doi.org/10.1182/blood.V114.22.591.591

Published: 2009

NARROW

Prognostic Characterization of Advanced Mastocytosis Patients Treated with Midostaurin According to Diagnosis and Mutation-Adjusted Risk Score: A Nation-Wide Ceremast Study of 170 Patients

GlcNAc is a mast-cell chromatin-remodeling oncometabolite that promotes systemic mastocytosis aggressiveness

Megakaryocyte TGFβ1 partitions erythropoiesis into immature progenitor/stem cells and maturing precursors

Megakaryocytic TGFβ1 Partitions Hematopoiesis into Amplifying Stem and Progenitor Cells and Maturing Effector Cells

Controlling Hematopoietic Stem Cell Quiescence By Ablating the TGFβ-Responsive, Hematopoietic-Hpecific Enhancer of CDKN1C (p57)

Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML

Genome-Wide Analysis of DNA Methylation Patterns Reveals Dynamic Epigenetic Regulation of the AML Genome After Decitabine Treatment.

Email alerts

ASH Publications

American Society of Hematology

Prognostic Characterization of Advanced Mastocytosis Patients Treated with Midostaurin According to Diagnosis and Mutation-Adjusted Risk Score: A Nation-Wide Ceremast Study of 170 Patients

GlcNAc is a mast-cell chromatin-remodeling oncometabolite that promotes systemic mastocytosis aggressiveness

Megakaryocyte TGFβ1 partitions erythropoiesis into immature progenitor/stem cells and maturing precursors

Megakaryocytic TGFβ1 Partitions Hematopoiesis into Amplifying Stem and Progenitor Cells and Maturing Effector Cells

Controlling Hematopoietic Stem Cell Quiescence By Ablating the TGFβ-Responsive, Hematopoietic-Hpecific Enhancer of CDKN1C (p57)

Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML

Genome-Wide Analysis of DNA Methylation Patterns Reveals Dynamic Epigenetic Regulation of the AML Genome After Decitabine Treatment.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only